Julio Scharfstein

Instituição:

Universidade Federal do Rio de Janeiro

Centro:

Centro de Ciências da Saúde

Unidade:

Instituto de Biofísica Carlos Chagas Filho

Departamento:

Programa de Imunobiologia/Biof

ORCID:

não disponível no Lattes


Formação:
  • Biortechnology Research Institute

    | Pós-Doutorado | 1991 - 1992
  • New York University

    | Mestrado | 1974 - 1976
  • New York University

    | Doutorado | 1974 - 1978
  • Israel Institute Of Technology

    Quimica | Graduação | 1969 - 1972
Laboratórios:
Nuvens de Palavras:
Artigos:
Nenhum artigo cadastrado
Eventos:

(0.00% eventos com DOI)

Titulo DOI Ano
Mouse fibroblasts guide IL-23 induction by Porphyromonas gingivalis-stimulated Dendritic Cells in gingipain-dependent mannar 2012
Intracardiac injection of Dm28c Trypanosoma cruzi provides a model of infection-associated myocarditis and heart fibrosis that depends critically on cooperative activation of the kallikrein/kinin sistem and the endothelin pathway 2012
Esploring the inflammatory role of mast cell/kallikrein-kinin cell pathway in the modulation of t cell responses against Trypanosoma cruzi. 2012
Mast cells propagate inflammation in peripheral sites of Trypanosoma cruzi infection through the activation of the kallikrein-kinin cascade 2012
Bradykinin B2 receptor is not required for tumor growth regression by radiotherapy 2011
Trypanosoma cruzi invades host cells through the activation of endothelin and kinin receptors: A converging pathway leading to chagasic vasculopathy 2011
Kinin danger signals proteolytically released by gingipain induce fimbriae-specific-IFN-gamma and IL-17-producing T cells in mice infected intramucosally by porphyromonas gingivalis 2009
Efficacy of vaccination against experimental trypanosoma cruzi infection is harnessed by bradykinin, a dentritic cell maturation signal that promotes the accumulation of type 1 effector CD8+ T cells in the heart 2009
Activation of bradykinin B2 receptors: an innate pathway guiding Tcell development in mice orally infected by the periodontal bacteria porphyromon 2009
The Colombian strain of Trypanosoma cruzi activates cardiovascular cells, rendering them susceptible to invasion via triggering of the inducible (B1) subtype of kinin receptors 2009
G-protein coupled receptors with distinct pharmacological specificities exert differential temporal and spatial control on the invasion of human smooth muscle cells by Trypanosoma cruzi 2009
Differential roles for G-protein coupled endothelin receptor subtypes (ETbR and ETaR) during the temporal progression of human smooth muscle cell invasion by Trypanosoma cruzi 2009
African trypanosome traversal of the human blood-brain barrier: A role for protease activated receptor signaling? 2009
Salivary gland homogenates enhances plasma leakage induced by L.chagasi promastigotes 2009
Gingipain and LPS from Porphyromonas gingivalis induce type-1 adaptive immunity via TLR2 and G-protein coupled Bradykinin B2 receptors, an innate axis activated at early stages of infection. 2008
Vaccines Containinng Bradykinin, A Type-1-Polarizing Adjuvant, Induce Immunoprotective Type-1 CD-8+Effector T Cells Against Trypanosoma cruzi. 2008
Bradykinin Elicits Eosinophil Lipid Body Biogenesis via PGE2 Autocrine Activity: Roles in Allergic Inflammation. 2008
In vivo targeting of dendritic cells with synthetic bradykinin : a novel strategy improving vaccine adjuvanticity 2007
Gingipain and LPS from Porphyromonas gingivalis, acting synergistically, link TLR2/B2R - driven inflammatory responses to adaptive immunity 2007
Activation of the innate kinin pathway is critical for type-1 immunity development and host resistance to acute infection with Trypanosoma cruzi 2007
Adaptive immunity in subcutaneous Trypanosoma cruzi infection is modulated by an innate pathway involving interdependent signaling of dendritic cells by C5a anaphylatoxins and bradykinin. 2007
SECRETION OF CXC CHEMOKINES BY MACROPHAGES LINKS TLR-2DEPENDENT SENSING OF Trypanosoma cruzi TO MECHANISMS THAT STEER INNATE IMMUNITY VIA BRADYKININ RECEPTORS 2006
LUTZOMYIA LONGIPALPIS SALIVARY GLAND HOMOGENATES INDUCE VASODILATION AND VASCULAR PERMEABILITY INCREASE IN THE HAMSTER CHEEK POUCH 2006
PORPHYROMONAS GINGIVALIS GINGIPAINS AND LIPOPOLYSACCHARIDES, ACTING COOPERATIVELY, DRIVE TH1 - TYPE IMMUNITY THROUGH THE KININ PATHWAY 2006
KININS MODULATE ANTIGEN-SPECIFIC T CELL RESPONSES IN INFLAMMATORY DRAINING LYMPH NODES 2006
SECRETION OF CXC CHEMOKINES BY MACROPHAGES LINKS TLR2 - DEPENDENT SENSING OF Trypanosoma cruzi TO MECHANISMS THAT STEER INNATE IMMUNITY VIA BRADYKININ RECEPTORS 2006
Activation of the innate kinin pathway is critical for development of host resistance to acute intraperitoneal infection with Trypanosoma cruzi 2006
Lutzomyia longipalpis salivary gland homogenates induce vasodilation and vascular permeability increase in the hamster cheek pouch 2006
TRYPANOSOMATID DRUG RESISTANCE : SOME CELLULAR FACETS 2006
CELL INVASION BY Trypanosoma cruzi EXTRACELLULAR AMASTIGOTES:ROLE OF CRUZIPAIN AND BRADIKININ CELL RECEPTORS 2006
Distinct Pathways of Smooth Muscle Invasion by Trypanosoma cruzi Dm28 Trypomastigotes: Differential Roles of G Protein-Coupled Receptors, Adenlyl Cyclase and PI3 Kinase Mediated Signaling. 2006
African trypanosomes traversal of the human blood-brain barrier requires cysteine protease-mediated calcium signaling. 2006
Inhibitors of Angiotensin-Converting Enzyme modify signaling pathways underlying invasion of endothelial cells by Trypanosoma cruzi 2006
STRUCTURAL BASIS FOR THE INHIBITORY FUNCTION OF CHAGASIN : DIFERENT REQUIREMENTS FOR THE INHIBITION OF PARASITE VERSUS HOST CYSTEINE PROTEASES. 2006
Kinin receptors promote Trypanosoma cruzi uptake by human circulating monocytes and induce modulatory changes in expression of cytokines and co-stimulatory molecules 2006
SECRETION OF CXC CHEMOKINES BY MACROPHAGES LINKS TLR2-DEPENDENT SENSING OF Trypanosoma cruzi TO MECHANISMS THAT STEER INNATE IMMUNITY VIA BRADYKININ RECEPTORS 2006
Proteomic and Immunological Analysis of Trypanosoma cruzi Shed Vesicles Involved in Host Immunomodulation and Cell Invasion 2005
ALTERATIONS IN TRAFFIC AND PRO-CRUZIPAIN MATURATION IN Trypanosoma cruzi OVEREXPRESSING CHAGASIN 2005
THE SUBSTRATE SPECIFICITY OF THE CYSTEINE PEPTIDASE OF Trypanosoma b. brucei, BRUCIPAIN AND ITS INACTIVATION BY NATURAL CYSTEINE PEPTIDASE INHIBITORS 2005
POTENT INHIBITION OF CATHEPSIN F AND OF CYSTEINE PROTEASES FROM TRYPANOSOMES (CRUZIPAIN AND BRUCIPAIN) BY THE PROPEPTIDE OF CRUZIPAIN 2005
INTERPLAY BETWEEN PARASITE CYSTEINE PROTEASES AND THE HOST KININ SYSTEM MODULATES VASCULAR LEAKAGE AND MACROPHAGE INFECTION BY PROMASTIGOTES OF THE Leishmania donovani complex 2005
KININOGEN HIGHJACKING BY L. CHAGASI PROMASTIGOTES: A POTENTIAL PATHWAY FOR TARGETED ACTIVATION OF BRADYKININ RECEPTORS OF MACROPHAGES 2005
ACTIVATION OF BRADYKININ B2 RECEPTORS BY Trypanosoma cruzi TRYPOMASTIGOTES MODULATES CXC-CHEMOKINE PRODUCTION BY MACROPHAGES 2005
BRADYKININ ADJUVANT CONVERTS EPIMASTIGOTE EXTRACTS INTO PROTECTIVE IMMUNOGENS BY DRIVING EFFECTOR-MEMORY T CELL DIFFERENTIATION VIA IL-12 INSTRUCTIVE PATHWAY 2005
GENDER AND GENETIC BACKGROUND DIFFERENTIALLY MODULATE KININ - DRIVEN LINKAGE OF INFLAMMATION TO INNATE AND TYPE-1 ADAPTIVE IMMUNITY IN MICE INFECTED BY Trypanosoma cruzi 2005
ACTIVATION OF THE KININ PATHWAY INTEGRATES INFLAMMATION TO INNATE AND ADAPTIVE IMMUNITY IN Trypanosoma cruzi INFECTION 2004
CHRONIC HEART FIBROSIS IS ATTENUATED IN B1 KNOCKOUT MICE INFECTED BY Trypanosoma cruzi 2004
CHRONIC HEART FIBROSIS IS ATTENUATED IN B1 KNOCKOUT MICE INFECTED BY Trypanosoma cruzi 2004
Leishmania donovani PROMASTIGOTES ELICIT MICROVASCULAR LEAKAGE AND INFLAMMATION BY ACTIVATING THE KININ PATHWAY THROUGH THE ACTIVITY OF CYSTEINE PROTEINASES 2004
BRADYKININ - DRIVEN ACTIVATION OF DENDRITIC CELLS : NEW STRATEGIES FOR ADJUVANT DEVELOPMENT AND VACCINE PRODUCTION 2004
Insights into the molecular mechanisms of endothelial kinin-receptor activation by Trypanosoma cruzi. 2002
Obtention and molecular characterization of transgenic sugarcane plants expressing a new cysteine proteinase inhibitor. 2002
Targeting of Trypanosoma cruzi cysteine proteinases by synthetic inhibitors depends on endocytosis. 2002
Heparan sulfate modulates kinin release by Trypanosoma cruzi through the activity of cruzipain 2002
HEPARAN SULFATE MODULATE KININ-RELEASE BY TRYPANOSOMA CRUZI THROUGH THR ACTIVITY OF CRUZIPAIN 2001
ROLE OF CRUZIPAIN IN THE ACTIVATION OF THE KININ CASCADE BY TRYPANOSOMA CRUZI TRYPOMASTIGOTES 2001
CHARACTERIZATION OF CHAGASIN-LIKE CYSTEINE PROTEASE INHIBITORS IN LEISHMANIA AMAZONENSIS, LEISHMANIA DONOVANI AND TRITRICHOMONAS FOETUS 2001
INTRACELLULAR LOCALIZATION AND SECRETION OF ACID PHOSPHATASE ACTIVITY IN ACANTHAMOEBA POLYPHAGA TROPHOZOITES 2001
ACTIVATION OF THE INDUCIBLE B1-KININ RECEPTOR (B1) BY TRYPANOSOMA CRUZI : HOST CELL SUSCEPTIBILITY TO 2001
INVOLVEMENT OF THE B2 - KININ RECEPTOR SUBTYPE IN MICROVASCULAR RESPONSES INDUCED BY TRYPANOSOMA CRUZI TRYPOMASTIGOTES IN VIVO 2001
Expression of cruzipain and of a cathepsin B-like target (Tc-cb) is inverted in a Trypanosoma cruzi cell line displaying resistance to synthetic inhibitors of cysteine-proteinases. 1999
Trypanosoma cruzi invasion of endothelial cells is potentiated by kinin-induced stimulation of G protein-coupled bradykinin receptors. 1999
Characterization of the substrate specificity of cysteine protease isoforms from T. cruzi: a comparative study between cruzipaina 2 and cruzain. 1999
Gene transfection of Trypanosoma cruzi with a minor cysteine-protease isoform (cruzipain 2), but not with cruzain, potentiates trypomastigote infectivity in mammalian cells in vitro. 1999
Cloning and expression of chagasin, a cysteine peptidase inhibitor of T. cruzi. 1st International Protein Society Meeting, Mackinac Island, MI, Sept. 25-30, 1999 1999
Immunochemical characterization, subcellular distribution and functional properties of chagasin, a Trypanosoma cruzi cysteine peptidase inhibitor. 1999
The transfection of T. cruzi cell lines with the gene of the cysteine protease isoform cruzipain 2 enhances parasite infectivity in host cells. 1998
Trypanosoma cruzi resistance to synthetic inhibitors of cysteine-proteinases correlates with changes in the expression of target enzymes and membrane permeability 1998
Trypanosoma cruzi inhibitor of cysteine proteases: biochemical characterization of natural form of chagasin 1998
Recombinant cysteine protease isoforms from Trypanosoma cruzi (cruzain and cruzipain 2) show marked differences to inhibitor sensitivity. 1998
R-chagasin, a potent inhibitor of papain-like cysteine-proteinases, reduces host-cell susceptibility to invasion by Trypanosoma cruzi trypomastigotes. 1998
Inhibition studies of cysteine proteases from trypanosoma cruzi by molecular modeling. 1998
Immunochemical characterization of cruzipain isoforms during T. cruzi development. Mem. Inst. Oswaldo Cruz. 1998
Exploiting Trypanosoma cruzi as a source of natural protein inhibitors of cysteine-proteinases: the case of chagasin 1998
Inhibition of trypanosomal cysteine proteinases by their pro-peptide. 1998
Molecular Modeling of the Inhibition of Cysteine-proteases from T. cruzi by E-64. 1998
Molecular characterization of chagasin, a T. cruzi inhibitor of papain-like cysteinyl-proteinases. 1998
Endothelial cell interactions with Trypanosoma cruzi cysteine proteinases: possible role in microvascular pathology. 1997
Biochemical characterization and subcellular localization of the endogenous T. cruzi inhibitor of cysteine proteases. 1997
Multiple mechanisms determine drug-resistance against peptidyl-based inhibitors of T. cruzi cysteine-proteases. 1997
Preliminary characterization of Trypanosoma cruzi cell lines transfected with genes encoding for the cysteine protease isoform cruzipain 2. 1997
Recombinant cruzipain induces T. cruzi specific Th1 and Mucosal IgA responses 1997
Characterization Of A Trypanosoma Cruzi Population Resistant To Synthetic Irrecersible Cysteine Protease Inhibitors. 1996
Cloning And Expression Of A Novel T.Cruzi Inhibitor Of Cysteinyl Proteinases. 1996
Chronic Chagasic Myocardiopahy In Humans: Identification Of Cruzipain Antigens In Inflammatory Sites. 1996
Cd8+ T Cells From Chronic Chagasic Patients Against Self Lisosomal Cathepsins: Molecular Mimicry? 1996
The Kinin Releasing Activity Of Cysteinyl Proteinases From Trypanosomacruzi: A Factor Of Parasite Virulence And Pathogenicity? 1996
In Vitro Study Of Natural Substrates Degradation By The Cysteine Proteinase From Trypanosoma Cruzi. 1996
Role Of Proteasomes In Remodeling Of A Protozoan Parasite. 1996
Trypanosoma Cruzi Cysteine-Proteinases (Cruzipains) Induced Plasma Leakage In Post-Capillary Venules. 1996
The major cysteine proteinase from Trypanosoma cruzi: phenotypic characterization of a parasite sub-population selected for resistance against irreversible synthetic inhibitors. 1996
Trypanosoma cruzi cysteine-proteinases (cruzipains) induced Plasma Leakage in post-capillary venules. 6th World Congress for Microcirculation, Munich, Germany, 25-20 de Agosto de 1996. 1996
Role of proteasomes in remodeling of a protozoan parasite. 1996
Alternative Cruzipain T Cell Epitopes Recognition During Infection By T.Cruzi. 1995
Investigation Of The Substrate Specificity Of Cruzipain Through The Use Of Cystatin-Derived Substrates. 1995
Affinity Labelling Of Cruzipain By Cystatin-Derived Peptidyl Diazomethylketones. 1995
The Minor Cysteine Proteinase From Trypanosoma Cruzi:Identification Inparasite Populations Selected For Resistance To Synthetic Inhibitors. 1995
Human T Cell Responses Against T.Cruzi Cysteine-Proteases (Cruzipain):Uptake By Monocyte 2-Macroglobulin Receptors Enhances Antigen- Presenting Cell Function. 1995
Isoform-Specific Or Conserved Cruzipain T Cell Epitopes Are Preferentially Recognized During Human Infection By T. Cruzi. 1995
Asma Bronquica:Caracterizacao Molecular dos Principais Alergenos de Acaros da Poeira Domiciliar. 1995
T Cell Responses Against Cruzipains: Specific And Conserved Epitopes Are Recognized During Human Infection By T.Cruzi. 1995
The Cysteinyl Proteinase Of Trypanosoma Cruzi Induces Murine Cd4+Th1 Cells To Produce Ifn-Y. 1995
Human T Cell Responses Against T.Cruzi Cysteine-Proteinases: Uptake By Monocyte,(2-Macroglobulin Receptors Enhances Antigen-Presenting Cell Function. 1995
Multiple Peptide Solid-phase Synthesis And Development Of Peptide Library For Mapping The Active Site Of Endoproteases. 1995
Synthesis Of Coumarin-Containing Peptides And Their Hydrolysis By Cysteine Proteases. 1995
Respostas de células T humanas contra a principal cisteíno-proteinase do T. cruzi: função do receptor de (2-macroglobulina. 1995
The cysteinyl proteinase of Trypanosoma cruzi induces murine CD4+ TH1 cells to produce IFN-(. 9th International Congress of Immunology, São Francisco, Califórnia, EUA, 23-29 de Julho de 1995 1995
T cell responses against cruzipains: specific and conserved epitopes are recognized during human infection by T.cruzi. 1995
The Major T.Cruzi Cysteine Proteinase (Cruzipain):Involvement Of The A2-Macroglobulin Receptor In Antigen Presentation To Human T Lymphocytes. 1994
Quantification Of Cruzipain-Reactive T Cell In The Blood Of Chronic Chagasic Patients. 1994
T Cell Responses Against T.Cruzi Cysteine Proteinases(Cruzipains): Isoform-Specific And Conserved Epitopes Are Recognized During Human Infection. 1994
Preliminary Characterization Of Recombinant Cruzipain 2, A New Cysteine Protease Isoform From Trypanosoma Cruzi. 1994
Inhibitors Of The Major Cysteine Proteinase From Trypanosoma Cruzi (Cruzipain): Selection Of Parasite Resistance To Peptidyl Diazomethylketones. 1994
Interaction Between The Major T.Cruzi Cysteine Proteinase (Cruzipain) Antigen And The Human Plasma Inhibitor X2-Macroglobulin. 1994
Immunodominant Antibody And T Cell Epitopes Map To Different Domains Of Cruzipain. 1994
Human T Cell Responses To Cruzipain: Frequency Analysis And Characterization Of Immunodominant Epitopes. 1994
Differential Localization Of The Major Cysteine Proteinase Of Trypanosoma Cruzi During Its Intracellular Cycle In Heart Muscle Cell. 1994
Inhibitors Of The Major Cysteine Proteinase From Trypanosoma Cruzi: Selection Of Parasite Resistamce To Peptidyl Diazomethyl Ketones. 1994
The Major Cysteine Proteinase Of Trypanosoma Cruzi: Biochemical Characterization With The Human Plasma Inhibitor A2-Macroglobulin. 1994
Protease-Inhibitor Based Capture Immunoassay (Pin-Elisa) Allows For The Detection Of Antigenic Cysteine Proteinases From Parasitic Protozoa. 1994
Identification Of New Cysteine Protease Gene Isoforms From Trypanosomacruzi. 1994
The major T. cruzi cysteine proteinase (cruzipain): involvement of the a2-macroglobulin receptor in antigen presentation to human T lymphocytes. 1994
Differential localization of the major cysteine proteinase of Trypanosoma cruzi during its intracellular cycle in heart muscle cells. 1994
Independence Of Antibody And Cystatin C Binding Sites On The Surface Of Cystenyl Proteinases From T.Cruzi And Leishmania As Defined By A Novel Protease Inhibitor Capture Immunoassay (Pin-Elisa). 1993
Pin-Elisa: A General Screening Method For The Identification Of Antigenic Cysteinyl Proteinases. 1993
Partial Mapping Of T Cell Epitopes On The Major T. Cruzi Cysteinyl Proteinase. 1993
Partial Mapping of T cell epitopes on the major T. cruzi cysteinyl proteinase. XVIII Congresso Brasileiro de Imunologia. Águas de Lindóia, SP, Setembro de 1993 1993
Partial Mapping of T cell epitopes on the major T. cruzi cysteinyl proteinase. 1993
Partial Mapping of T cell epitopes on the major T. cruzi cysteinyl proteinase. 1993
Temperature Dependent Substrate Inhibition Of The Cysteine Protease (GP57/51) From Tryopanosoma Cruzi. 1992
Trypanosoma cruzi proteinase (GP 57/51): Structural, functional and immunological properties. 1991
Expression of proteinases during Trypanosoma cruzi metacyclogenesis. 1991
Trypanosoma cruzi: inhibitors of major cysteinyl proteinase (GP 57/51) impair host cell invasion and arrest intracellular development in vitro. 1991
Preliminary analysis of epitopes mapped within the central domain of the major cysteinevproteinase (GP 57/51) of T. cruzi. 1991
T. cruzi cysteine proteinase (GP 57/51): cellular immune response against papain (Papaya latex Protease) among chagasic patients - A possible cross-reaction? 1991
T.Cruzi Cysteine Proteinase (Gp57/51): Celular Immune Cross Reactivitywith Papaya Latex Protease (Papain). 1990
Peptidyl diazomethyl ketonas inhibit T. cruzi infection of heart muscle cells in vitro. 1990
T.Cruzi Gp57/51 Autoproteolysis: An Expression Of Its Proteinase Function? 1989
Frequency Of Reactive T Cell To Various Leishmania Brasiliensis(L.B.B.) Antigen Fractions In The Lesion Of Human American Cutaneous Leishmaniasis (Acl). Preliminary Results. 1989
Gp57/51 Of Trypamosoma Cruzi: Antigenic Changes Associated With Auto- Proteolysis. 1989
Glicoproteina Gp57/51 do T.Cruzi: Influencia da Resposta Imune Especifica Sobre O Curso da Infeccao Chagasica Experimental. 1989
Alteracoes Na Antigenicidade da Gp57/51 de Trypanosoma Cruzi:Eviden- Cias A Favor de Um Mecanismo de Auto-Fragmentacao. 1989
Modulação por anticorpos anti-Thy 1 da ativação de linfócitos T mediada por anticorpos anti- CD3. 1989
Trypanosoma cruzi GP 57/51: antigenic changes associated with autolytic fragmentation are prevented by serine protease inhibitors. 1989
Partial characterization of phospholipases in T. cruzi. 1989
Tcell responses against T. cruzi GP57/51: characterization of the responding phenotype in immunized mice. 1989
GP57/51 of Trypanosoma cruzi: antigenic changes associated with auto-proteolysis. 1989
Correlation Between Gp57/51 And The Outative Adhesion Proteins From Differentiating Epimastigotes. 1988
GP51 of Trypanosoma cruzi: conformational epitope defined with monoclonal antibodies. 1988
Isolation And Characterizationof Phosphatidyl-Inositol Specific Phospholipase C (Pi-Plc) From Trypanosoma Cruzi. 1987
Gp51 Of Trypanosoma Cruzi: Epitope Analysis By Monoclonal Antibodies. 1987
Recognition Of Various Leishmania Braziliensis Brasiliensis(L.B.B.) Antigen Fractions By Homogeneous T Cell Populations Derived From Peripheral Blood Of Cutaneous And Mucosal Leishmaniasis Patients. 1987
Phosphatidylinositol Specific Phospholipase C (Piplc) In T.Cruzi Epimastigotes. 1986
Isolation Of Gp57/51 Antigen Of T.Cruzi By Fast Performance Liquid/ Chromatografy. 1986
Antigenic Properties Of Purified Gp 51 Of T.Cruzi 1986
Homogeneous Human T Cell Populations With Specificity For Leishmania Species. Responsiveness To Fractions Of Leishmania Antigen. 1985
Avaliacao da Fracao Semipurificada (E) e da Glicoproteina Go-25 do Trypanosoma Cruzi Comoantigenos No Teste Imunoenzimatico Para A Doen- Ca de Chagas. 1985
Identification Of T.Cruzi Trypanosomatids. 1985
Involvement Of Carbohydrate Structures In The Antigenicity Of T. Cruziglycoproteins Gp-25 And Gp-50/55. 1985
Characterization Of A Cross-Reactive Antigen Of T.Cruzi Defined With Sleeping Sickness Sera. 1985
Gp-25 Antigen Of T.Cruzi:Identification Of A 60kd Precursor With Monoclonal Antibodies. 1985
Homogeneous human T cell populations with specificity for Leishmania species. Responsiveness to fractions of Leishmania antigen. 1985
Trypanosoma Cruzi Infection Of Human Muscle Cell Is Inhibited By Antibodies To Parasite Surface Antigens. 1983
Antibodies To T.Cruzi Surface Glycoprotein G-25 Inhibit Infection Of Human Smooth Muscle Cells In Vitro. 1983
Conservation Of T. Cruzi Antigens: Evidence From Mrna In Vitro Translation. 1983
Antibodies to T. cruzi surface glycoprotein G-25 inhibit infection of human smooth muscle cells in vitro. 1983
Antibodies To G25k - Antigen Protect Human Muscle Cells From In Vitro Infection With Trypanosoma Cruzi. 1982
Molecular Characterization Of A Trypanosoma Cruzi Surface Antigen (25kdefined By Human Antibodies. 1982
The Effect Of Auronofin And Sodium Aurothiomalate On Casein Induced Experimental Amyloidosis. 1982
Isolation Of A Trypanosoma Cruzi Surface Antigen Defined By Human Antibodies. 1982
The effect of auronofin and sodium aurothiomalate on casein induced experimental amyloidosis. 1982
Characterization Of The Acute Phase Reaction In Experimental Chagas' Disease. 1980
Human C4-Binding Protein In Immune-Glomerulonephritis 1978
Presence Of A C4 Binding Protein In Human Serum. 1978
Publicações:
Minha Rede: